时间:2005-05-11
浏览量:3884
杨恒林1 刘德全2 董 莹1 杨品芳1
1.云南省疟疾防治研究所 思茅 665000 2.中国预防医学科学院寄生虫病研究所 上海 200025
全文发表于《中国寄生虫学与寄生虫病杂》1995年13卷2期111-113页
提要 :1992年应用体外微量法在中老边境测得我国境内恶性疟原虫对氯喹、哌喹、青蒿琥酯、蒿甲醚、蒿乙醚、还原青蒿素及咯萘啶抗性率,分别为97.0%、96.4%、12.1%、16.0%、6.2%、12.5%、34.5%;半数抑制量(ID50)依次为119.0、320 、7.2、295、0、74.4、5.4及31.9 nmol/L。老挝境内恶性疟原虫分离株对氯喹、派喹及咯萘啶的抗性率分别为9/10、8/10及1/5;ID50依次为114.0、166.9及16.4 nmol/L;对青蒿琥酯、蒿甲醚、高乙醚及还原青蒿素均敏感,ID50分别为5.0、91.6、56.7及4.4nmol/L。结果提示境内外恶性疟原虫株对氯喹的抗性程度相似,但对哌喹抗性程度境外明显低于境内。对青蒿琥酯、蒿甲醚、蒿乙醚及还原青蒿素的敏感性境外明显高于境内。
关键词:恶性疟原虫,体外测定,氯喹,哌喹,青蒿素类药物,咯萘啶
SENSITIVITY OF PLASMODIUM FALCIPARUM TO SEVEN ANTIMALARIALS IN CHINA-LAOS BORDER
Yang Henglin1,Liu Dequan2,Dong Ying1,Yang Pinfang1,Liu Ruijun2,
Zhang Bin2,Zhang Chunyong2
1 Institute of Malaria Prevention and Treatment of
2 Institute of Parasitic Diseases,Chinese
ABSTRACT.The sensitivity of P. falciparum to chloroquisne(CHL), piperaquine(PIP), artesunate(ATS),dihydroartemisinine(DAT), artemether
(ATM), arteethe(ATE) and pyronaridine(PRN)were assayed by in vitro microtechnique in China-Laos border in 1992. The resistance rates of isolates from the south of Yunnan of China in the border were 97.0%,96.4%,12.5%,16.0%,6.3% and 34.5%,respectively;ID50 were119.0,320,7.2,5.4,295.0,74.4,and 31.9 nmol/L,ID95 were 625.0, 2426.0,42.2,36.6,767.0 ,371.1 and 325.2nmol/L. The resistance rates of isolates from the north border of Laos were in order 9/10,8/10,1/5 to CHL,PIP,PRN,ID50 were 114.0,166.9,16.4 nmol/L,ID95 were 570.0,631.1 and 101.7 nmol/L. All the isolates from Laos were sensitive to ATS,DAT,ATM and ATE. ID50 were 5.0,4.4,91.6,and 56.7nmol/L,ID95 were 23.4,11.1,3276.1 and 223.9 nmol/L,respectively.
The results indicate that P. falciparum in the border was highly resistant to CHL and PIP, while most of the isolates were susceptible to the other 5 of the above-mentioned drugs. A comparison between the isolates from
Key words:P. falciparum, in vitro assay, chloroquine,piperaquine,Artemisinine derivatives, pyronaridine
注:转载请注明出处、谢谢合作
版权所有 Copyright © 云南省寄生虫病防治所 滇ICP备05004264号-3 滇公网安备 53080202000356号
技术支持:川海科技
本站部分素材源于网络,如有侵权,请联系作者删除!